Trial Search
Current Search Criteria:
Intervention: CD19 CAR T-Cell(CAT19T2)
Found 1 matching trials
CD19 CAR T-cell Target Relapsed/Refractory Acute B Cell Leukemia/Lymphoma
PHASE1This study aims to evaluate the safety and efficacy of humanized Anti-CD19 ...
Status
Withdrawn
Location
Guangdong Zhaotai Cell Bio-tech Co., LTD
Start Date
2022-12-01
Trial ID
NCT05613348
Treatments Being Tested